Cytokeratin 5/6, c-Met expressions, and PTEN loss prognostic indicators in triple-negative breast cancer
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cytokeratin 5/6, c-Met expressions, and PTEN loss prognostic indicators in triple-negative breast cancer
Authors
Keywords
Triple-negative breast cancer, CK5/6, PTEN, c-Met
Journal
MEDICAL ONCOLOGY
Volume 31, Issue 1, Pages -
Publisher
Springer Nature
Online
2013-12-10
DOI
10.1007/s12032-013-0801-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- High MET expression is an adverse prognostic factor in patients with triple-negative breast cancer
- (2013) F Zagouri et al. BRITISH JOURNAL OF CANCER
- Predictors of early distant metastasis in women with breast cancer
- (2013) Erick Sta. Rosa Mendoza et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Cross-platform pathway-based analysis identifies markers of response to the PARP inhibitor olaparib
- (2012) Anneleen Daemen et al. BREAST CANCER RESEARCH AND TREATMENT
- MET in gastric carcinomas: comparison between protein expression and gene copy number and impact on clinical outcome
- (2012) H E Lee et al. BRITISH JOURNAL OF CANCER
- Frequency of mesenchymal-epithelial transition factor gene (MET) and the catalytic subunit of phosphoinositide-3-kinase (PIK3CA) copy number elevation and correlation with outcome in patients with early stage breast cancer
- (2012) Ana M. Gonzalez-Angulo et al. CANCER
- Bcl-2 and BLIMP-1 expression predict worse prognosis in gastric diffuse large B cell lymphoma (DLCBL) while other markers for nodal DLBCL are not useful
- (2012) Maialen Martin-Arruti et al. HISTOPATHOLOGY
- Plasma Cell Membrane Localization of c-MET Predicts Longer Survival in Patients with Malignant Mesothelioma: A Series of 157 Cases from the MESOPATH Group
- (2012) Guénaëlle Levallet et al. Journal of Thoracic Oncology
- Prognostic value of tumor growth factor levels during chemotherapy in patients with metastatic colorectal cancer
- (2012) Mevlüde İnanç et al. MEDICAL ONCOLOGY
- Evaluation of the association of PIK3CA mutations and PTEN loss with efficacy of trastuzumab therapy in metastatic breast cancer
- (2011) E. Razis et al. BREAST CANCER RESEARCH AND TREATMENT
- Differential roles of trans-phosphorylated EGFR, HER2, HER3 and RET as heterodimerisation partners of MET in lung cancer with MET amplification
- (2011) J Tanizaki et al. BRITISH JOURNAL OF CANCER
- CpG island hypermethylation ofBRCA1and loss of pRb as co-occurring events in basal/triple-negative breast cancer
- (2011) Olafur Andri Stefansson et al. Epigenetics
- Induction of MET by Ionizing Radiation and Its Role in Radioresistance and Invasive Growth of Cancer
- (2011) Francesca De Bacco et al. JNCI-Journal of the National Cancer Institute
- Triple-negative breast cancer: immunohistochemical correlation with basaloid markers and prognostic value of survivin
- (2009) Gamze Gokoz Dogu et al. MEDICAL ONCOLOGY
- Basal-Like Breast Cancer Defined by Five Biomarkers Has Superior Prognostic Value than Triple-Negative Phenotype
- (2008) M. C.U. Cheang et al. CLINICAL CANCER RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started